Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 199240 entries
Sorted by: Best Match Show Resources per page
NTP Toxicology and Carcinogenesis Studies of Triamterene (CAS No. 396-01-0) in F344/N Rats and B6C3F1 Mice (Feed Studies).

National Toxicology Program technical report series

[No authors listed]
PMID: 12616291
Natl Toxicol Program Tech Rep Ser. 1993 Dec;420:1-367.

Triamterene is a potassium-sparing diuretic used in the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and other diseases in which edema may occur. Toxicity and carcinogenicity studies were conducted by administering triamterene (greater than...

Cite
NTP Toxicology and Carcinogenesis Studies of Triamterene (CAS No. 396-01-0) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser. 1993;420:1-367
(1993). NTP Toxicology and Carcinogenesis Studies of Triamterene (CAS No. 396-01-0) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program technical report series, 4201-367.
"NTP Toxicology and Carcinogenesis Studies of Triamterene (CAS No. 396-01-0) in F344/N Rats and B6C3F1 Mice (Feed Studies)." National Toxicology Program technical report series vol. 420 (1993): 1-367.
NTP Toxicology and Carcinogenesis Studies of Triamterene (CAS No. 396-01-0) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser. 1993 Dec;420:1-367. PMID: 12616291.
Copy Download .nbib Format: NLM
NTP Toxicology and Carcinogenesis Studies of Barium Chloride Dihydrate (CAS No. 10326-27-9) in F344/N Rats and B6C3F1 Mice (Drinking Water Studies).

National Toxicology Program technical report series

[No authors listed]
PMID: 12616299
Natl Toxicol Program Tech Rep Ser. 1994 Jan;432:1-285.

Barium chloride dihydrate, a white crystalline granule or powder, is used in pigments, aluminum refining, leather tanning and coloring, the manufacture of magnesium metal, ceramics, glass, and paper products, as a pesticide, and in medicine as a cardiac stimulant....

Cite
NTP Toxicology and Carcinogenesis Studies of Barium Chloride Dihydrate (CAS No. 10326-27-9) in F344/N Rats and B6C3F1 Mice (Drinking Water Studies). Natl Toxicol Program Tech Rep Ser. 1994;432:1-285
(1994). NTP Toxicology and Carcinogenesis Studies of Barium Chloride Dihydrate (CAS No. 10326-27-9) in F344/N Rats and B6C3F1 Mice (Drinking Water Studies). National Toxicology Program technical report series, 4321-285.
"NTP Toxicology and Carcinogenesis Studies of Barium Chloride Dihydrate (CAS No. 10326-27-9) in F344/N Rats and B6C3F1 Mice (Drinking Water Studies)." National Toxicology Program technical report series vol. 432 (1994): 1-285.
NTP Toxicology and Carcinogenesis Studies of Barium Chloride Dihydrate (CAS No. 10326-27-9) in F344/N Rats and B6C3F1 Mice (Drinking Water Studies). Natl Toxicol Program Tech Rep Ser. 1994 Jan;432:1-285. PMID: 12616299.
Copy Download .nbib Format: NLM
NTP Toxicity Study Report on the atmospheric characterization, particle size, chemical composition, and workplace exposure assessment of cellulose insulation (CELLULOSEINS).

Toxicity report series

Morgan DL.
PMID: 17160106
Toxic Rep Ser. 2006 Aug;(74):1-62, A1-C2.

UNLABELLED: Cellulose insulation (CI) is a type of thermal insulation produced primarily from recycled newspapers. The newspapers are shredded, milled, and treated with fire-retardant chemicals. The blowing process for installing CI generates a significant quantity of airborne material that...

Cite
Morgan DL. NTP Toxicity Study Report on the atmospheric characterization, particle size, chemical composition, and workplace exposure assessment of cellulose insulation (CELLULOSEINS). Toxic Rep Ser. 2006;(74):1-62, A1-C2
Morgan, D. L. (2006). NTP Toxicity Study Report on the atmospheric characterization, particle size, chemical composition, and workplace exposure assessment of cellulose insulation (CELLULOSEINS). Toxicity report series, (74), 1-62, A1-C2.
Morgan, Daniel L. "NTP Toxicity Study Report on the atmospheric characterization, particle size, chemical composition, and workplace exposure assessment of cellulose insulation (CELLULOSEINS)." Toxicity report series vol. ,74 (2006): 1-62, A1-C2.
Morgan DL. NTP Toxicity Study Report on the atmospheric characterization, particle size, chemical composition, and workplace exposure assessment of cellulose insulation (CELLULOSEINS). Toxic Rep Ser. 2006 Aug;(74):1-62, A1-C2. PMID: 17160106.
Copy Download .nbib Format: NLM
Toxicology studies of sodium bromate (CAS No. 7789-38-0) in genetically modified (FVB Tg.AC Hemizygous) mice (dermal and drinking water studies) and carcinogenicity studies of sodium bromate in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficient] mice (drinking water studies).

National Toxicology Program genetically modified model report

[No authors listed]
PMID: 18784759
Natl Toxicol Program Genet Modif Model Rep. 2007 Mar;(6):1-169.

UNLABELLED: Bromate is a drinking water disinfection by-product formed during the ozonation of source water containing bromide. Sodium bromate is also used as an analytical reagent, in the oxidation of sulfur and vat dyes, and for cleaning boilers. As...

Cite
Toxicology studies of sodium bromate (CAS No. 7789-38-0) in genetically modified (FVB Tg.AC Hemizygous) mice (dermal and drinking water studies) and carcinogenicity studies of sodium bromate in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficient] mice (drinking water studies). Natl Toxicol Program Genet Modif Model Rep. 2007;(6):1-169
(2007). Toxicology studies of sodium bromate (CAS No. 7789-38-0) in genetically modified (FVB Tg.AC Hemizygous) mice (dermal and drinking water studies) and carcinogenicity studies of sodium bromate in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficient] mice (drinking water studies). National Toxicology Program genetically modified model report, (6), 1-169.
"Toxicology studies of sodium bromate (CAS No. 7789-38-0) in genetically modified (FVB Tg.AC Hemizygous) mice (dermal and drinking water studies) and carcinogenicity studies of sodium bromate in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficient] mice (drinking water studies)." National Toxicology Program genetically modified model report vol. ,6 (2007): 1-169.
Toxicology studies of sodium bromate (CAS No. 7789-38-0) in genetically modified (FVB Tg.AC Hemizygous) mice (dermal and drinking water studies) and carcinogenicity studies of sodium bromate in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficient] mice (drinking water studies). Natl Toxicol Program Genet Modif Model Rep. 2007 Mar;(6):1-169. PMID: 18784759.
Copy Download .nbib Format: NLM
Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.

Ontario health technology assessment series

[No authors listed]
PMID: 23074487
Ont Health Technol Assess Ser. 2006;6(17):1-121. Epub 2006 Aug 01.

OBJECTIVE: The Ontario Health Technology Advisory Committee asked the Medical Advisory Secretariat (MAS) to conduct a health technology assessment on energy delivery systems for the treatment of benign prostatic hyperplasia (BPH).CLINICAL NEED: TARGET POPULATION AND CONDITION BPH is a...

Cite
Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(17):1-121
(2006). Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis. Ontario health technology assessment series, 6(17), 1-121.
"Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis." Ontario health technology assessment series vol. 6,17 (2006): 1-121.
Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(17):1-121. Epub 2006 Aug 01. PMID: 23074487; PMCID: PMC3379165.
Copy Download .nbib Format: NLM
Pergolide : A Review of its Pharmacology and Therapeutic Use in Parkinson's Disease.

CNS drugs

Markham A, Benfield P.
PMID: 27520755
CNS Drugs. 1997 Apr;7(4):328-40. doi: 10.2165/00023210-199707040-00005.

SYNOPSIS: The semisynthetic ergotine dopamine agonist pergolide has demonstrated activity at pre- and postsynaptic dopamine D2 receptors in vitro and in vivo animal studies. However, unlike other dopamine agonists such as bromocriptine, pergolide also has agonist activity at dopamine...

Cite
Markham A, Benfield P. Pergolide : A Review of its Pharmacology and Therapeutic Use in Parkinson's Disease. CNS Drugs. 1997;7(4):328-40doi: 10.2165/00023210-199707040-00005.
Markham, A., & Benfield, P. (1997). Pergolide : A Review of its Pharmacology and Therapeutic Use in Parkinson's Disease. CNS drugs, 7(4), 328-40. https://doi.org/10.2165/00023210-199707040-00005
Markham, A, and Benfield, P. "Pergolide : A Review of its Pharmacology and Therapeutic Use in Parkinson's Disease." CNS drugs vol. 7,4 (1997): 328-40. doi: https://doi.org/10.2165/00023210-199707040-00005
Markham A, Benfield P. Pergolide : A Review of its Pharmacology and Therapeutic Use in Parkinson's Disease. CNS Drugs. 1997 Apr;7(4):328-40. doi: 10.2165/00023210-199707040-00005. PMID: 27520755.
Copy Download .nbib Format: NLM
Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.

Critical reviews in toxicology

Willhite CC, Ball GL, McLellan CJ.
PMID: 22512666
Crit Rev Toxicol. 2012 May;42(5):358-442. doi: 10.3109/10408444.2012.674101.

Maximum contaminant levels are used to control potential health hazards posed by chemicals in drinking water, but no primary national or international limits for aluminum (Al) have been adopted. Given the differences in toxicological profiles, the present evaluation derives...

Cite
Willhite CC, Ball GL, McLellan CJ. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water. Crit Rev Toxicol. 2012;42(5):358-442doi: 10.3109/10408444.2012.674101.
Willhite, C. C., Ball, G. L., & McLellan, C. J. (2012). Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water. Critical reviews in toxicology, 42(5), 358-442. https://doi.org/10.3109/10408444.2012.674101
Willhite, Calvin C, et al. "Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water." Critical reviews in toxicology vol. 42,5 (2012): 358-442. doi: https://doi.org/10.3109/10408444.2012.674101
Willhite CC, Ball GL, McLellan CJ. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water. Crit Rev Toxicol. 2012 May;42(5):358-442. doi: 10.3109/10408444.2012.674101. PMID: 22512666.
Copy Download .nbib Format: NLM
Effectiveness of ondansetron as an adjunct to lidocaine intravenous regional anesthesia on tourniquet pain and postoperative pain in patients undergoing elective hand surgery: a systematic review protocol.

JBI database of systematic reviews and implementation reports

Badeaux J, Bonanno L, Au H.
PMID: 26447005
JBI Database System Rev Implement Rep. 2015 Jan;13(1):27-38. doi: 10.11124/jbisrir-2015-1768.

REVIEW QUESTION/OBJECTIVE: The objective of this quantitative systematic review is to determine the effects of ondansetron as an adjunct to lidocaine on the tourniquet pain and postoperative pain of American Society of Anesthesiologists (ASA) class 1 or 2 adult...

Cite
Badeaux J, Bonanno L, Au H. Effectiveness of ondansetron as an adjunct to lidocaine intravenous regional anesthesia on tourniquet pain and postoperative pain in patients undergoing elective hand surgery: a systematic review protocol. JBI Database System Rev Implement Rep. 2015;13(1):27-38doi: 10.11124/jbisrir-2015-1768.
Badeaux, J., Bonanno, L., & Au, H. (2015). Effectiveness of ondansetron as an adjunct to lidocaine intravenous regional anesthesia on tourniquet pain and postoperative pain in patients undergoing elective hand surgery: a systematic review protocol. JBI database of systematic reviews and implementation reports, 13(1), 27-38. https://doi.org/10.11124/jbisrir-2015-1768
Badeaux, Jennifer, et al. "Effectiveness of ondansetron as an adjunct to lidocaine intravenous regional anesthesia on tourniquet pain and postoperative pain in patients undergoing elective hand surgery: a systematic review protocol." JBI database of systematic reviews and implementation reports vol. 13,1 (2015): 27-38. doi: https://doi.org/10.11124/jbisrir-2015-1768
Badeaux J, Bonanno L, Au H. Effectiveness of ondansetron as an adjunct to lidocaine intravenous regional anesthesia on tourniquet pain and postoperative pain in patients undergoing elective hand surgery: a systematic review protocol. JBI Database System Rev Implement Rep. 2015 Jan;13(1):27-38. doi: 10.11124/jbisrir-2015-1768. PMID: 26447005.
Copy Download .nbib Format: NLM
Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).

Trials

Ye Q, Wang H, Xia X, Zhou C, Liu Z, Xia ZE, Zhang Z, Zhao Y, Yehenala J, Wang S, Zhou G, Hu K, Wu B, Wu CT, Wang S, He Y.
PMID: 32532356
Trials. 2020 Jun 12;21(1):520. doi: 10.1186/s13063-020-04380-5.

OBJECTIVES: To assess the safety and therapeutic effects of allogeneic human dental pulp stem cells (DPSCs) in treating severe pneumonia caused by COVID-19.TRIAL DESIGN: This is a single centre, two arm ratio 1:1, triple blinded, randomized, placebo-controlled, parallel group,...

Cite
Ye Q, Wang H, Xia X, et al. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II). Trials. 2020;21(1):520doi: 10.1186/s13063-020-04380-5.
Ye, Q., Wang, H., Xia, X., Zhou, C., Liu, Z., Xia, Z. E., Zhang, Z., Zhao, Y., Yehenala, J., Wang, S., Zhou, G., Hu, K., Wu, B., Wu, C. T., Wang, S., & He, Y. (2020). Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II). Trials, 21(1), 520. https://doi.org/10.1186/s13063-020-04380-5
Ye, Qingsong, et al. "Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)." Trials vol. 21,1 (2020): 520. doi: https://doi.org/10.1186/s13063-020-04380-5
Ye Q, Wang H, Xia X, Zhou C, Liu Z, Xia ZE, Zhang Z, Zhao Y, Yehenala J, Wang S, Zhou G, Hu K, Wu B, Wu CT, Wang S, He Y. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II). Trials. 2020 Jun 12;21(1):520. doi: 10.1186/s13063-020-04380-5. PMID: 32532356; PMCID: PMC7290137.
Copy Download .nbib Format: NLM
[Nonarteritic ischemic optic neuropathy animal model and its treatment applications].

Nippon Ganka Gakkai zasshi

Chuman H.
PMID: 24864434
Nippon Ganka Gakkai Zasshi. 2014 Apr;118(4):331-61.

Nonarteritic ischemic optic neuropathy (NAION) is one of the most common acute unilaterally onset optic nerve diseases. One management problem in terms of NAION is the difficulty of differential diagnosis between NAION and anterior optic neuritis (ON). A second...

Cite
Chuman H. [Nonarteritic ischemic optic neuropathy animal model and its treatment applications]. Nippon Ganka Gakkai Zasshi. 2014;118(4):331-61
Chuman, H. (2014). [Nonarteritic ischemic optic neuropathy animal model and its treatment applications]. Nippon Ganka Gakkai zasshi, 118(4), 331-61.
Chuman, Hideki. "[Nonarteritic ischemic optic neuropathy animal model and its treatment applications]." Nippon Ganka Gakkai zasshi vol. 118,4 (2014): 331-61.
Chuman H. [Nonarteritic ischemic optic neuropathy animal model and its treatment applications]. Nippon Ganka Gakkai Zasshi. 2014 Apr;118(4):331-61. Japanese. PMID: 24864434.
Copy Download .nbib Format: NLM
Methods of milk expression for lactating women.

The Cochrane database of systematic reviews

Becker GE, Smith HA, Cooney F.
PMID: 27684560
Cochrane Database Syst Rev. 2016 Sep 29;9:CD006170. doi: 10.1002/14651858.CD006170.pub5.

BACKGROUND: Breastfeeding is important, however not all infants can feed at the breast and methods of expressing milk need evaluation.OBJECTIVES: To assess acceptability, effectiveness, safety, effect on milk composition, contamination and costs of methods of milk expression.SEARCH METHODS: We...

Cite
Becker GE, Smith HA, Cooney F. Methods of milk expression for lactating women. Cochrane Database Syst Rev. 2016;9:CD006170doi: 10.1002/14651858.CD006170.pub5.
Becker, G. E., Smith, H. A., & Cooney, F. (2016). Methods of milk expression for lactating women. The Cochrane database of systematic reviews, 9CD006170. https://doi.org/10.1002/14651858.CD006170.pub5
Becker, Genevieve E, et al. "Methods of milk expression for lactating women." The Cochrane database of systematic reviews vol. 9 (2016): CD006170. doi: https://doi.org/10.1002/14651858.CD006170.pub5
Becker GE, Smith HA, Cooney F. Methods of milk expression for lactating women. Cochrane Database Syst Rev. 2016 Sep 29;9:CD006170. doi: 10.1002/14651858.CD006170.pub5. PMID: 27684560; PMCID: PMC6457747.
Copy Download .nbib Format: NLM
Tatami Mats: A Source of Pitted Keratolysis in a Martial Arts Athlete?.

Acta dermatovenerologica Croatica : ADC

Balić A, Bukvić Mokos Z, Marinović B, Ledić Drvar D.
PMID: 29782305
Acta Dermatovenerol Croat. 2018 Apr;26(1):68-70.

Dear Editor, Pitted keratolysis (PK), also known as keratosis plantaris sulcatum, is a non-inflammatory, bacterial, superficial cutaneous infection, characterized by many discrete superficial crateriform ''pits'' and erosions in the thickly keratinized skin of the weight-bearing regions of the soles...

Cite
Balić A, Bukvić Mokos Z, Marinović B, et al. Tatami Mats: A Source of Pitted Keratolysis in a Martial Arts Athlete?. Acta Dermatovenerol Croat. 2018;26(1):68-70
Balić, A., Bukvić Mokos, Z., Marinović, B., & Ledić Drvar, D. (2018). Tatami Mats: A Source of Pitted Keratolysis in a Martial Arts Athlete?. Acta dermatovenerologica Croatica : ADC, 26(1), 68-70.
Balić, Anamaria, et al. "Tatami Mats: A Source of Pitted Keratolysis in a Martial Arts Athlete?." Acta dermatovenerologica Croatica : ADC vol. 26,1 (2018): 68-70.
Balić A, Bukvić Mokos Z, Marinović B, Ledić Drvar D. Tatami Mats: A Source of Pitted Keratolysis in a Martial Arts Athlete?. Acta Dermatovenerol Croat. 2018 Apr;26(1):68-70. PMID: 29782305.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 199240 entries